FDA requires boxed warnings for short-acting opioids
The Food and Drug Administration will require boxed warnings on the risks of abuse, misuse, addiction, overdose, and death for all immediate-release opioids.
The decision is part of the latest wave...
Source: Clinical Neurology News - Category: Neurology Source Type: news
More News: Addiction | Brain | Food and Drug Administration (FDA) | Neurology | Overdose | Substance Abuse | Warnings